Nerve cell insights shed light on equine grass sickness

Molecular changes linked to neurons offer clues to the processes involved in the fatal horse disease.

Insights into how nerve cells are affected by equine grass sickness could aid efforts to understand the predominantly fatal disease. 

Nerve tissue from affected horses showed signs of disruption to genes and proteins involved in the processes that enable cells to produce the energy they need to function. 

The findings provide a more detailed picture of the molecular changes associated with nerve degeneration in equine grass sickness, a disease of grazing horses thought to be caused by a neurotoxic microorganism or plant.  

These changes may contribute to the degeneration of nerve cells seen in equine grass sickness, which can impair control of the digestive system and lead to symptoms including intestinal paralysis and difficulty swallowing. The disease, which carries an 85 per cent fatality rate, occurs across Northern Europe, with the highest concentration of cases reported in the UK, particularly Scotland.

A brown, underweight horse affected by equine grass sickness stands in a stable.
Equine grass sickness is associated with weight loss.

Molecular changes

Findings could help scientists understand how equine grass sickness causes degeneration of the nervous system, particularly in parts controlling the digestive tract in horses. 

Researchers, both formerly and currently affiliated with the Royal (Dick) School of Veterinary Studies, examined nerve tissue from eight horses with the severe form of equine grass sickness, and compared these with samples from six unaffected horses. 

Affected horses showed reduced activity of genes and proteins involved in neurological functions, including communication between nerve cells and the function of mitochondria – the structures in cells that generate energy for normal activity.

Cellular damage

Researchers also found increased activity of genes and proteins associated with cellular stress, inflammation and cell death, adding to the molecular picture of how nerve cells are affected by the disease. 

Previous research involving the Royal (Dick) School of Veterinary Studies has suggested that nerve damage could be caused by a neurotoxic enzyme known as phospholipase A2, potentially produced by a microorganism or plant. 

The latest findings could provide researchers with additional evidence against which to assess potential causes of the disease, including candidate neurotoxins. Related work is currently seeking to develop lab models which could enable researchers to screen potential causal candidates, and investigate how they affect the nervous system. 

This research was published in Cells, in collaboration with colleagues now affiliated with the Universities of Queensland, Surrey, and Glasgow, with Keele and Nottingham Trent Universities. 

Equine grass sickness is a devastating disease, and despite decades of research we still do not know exactly how it is caused. These findings give us a better understanding of the biological processes taking place in affected nerve cells and add another piece to the puzzle.  

As we investigate potential toxins that may cause the disease, this information could help us determine which of those candidates most closely align with the processes identified in this study.

Image credit: Bryony Lancaster.

About the Royal (Dick) School of Veterinary Studies  

The Royal (Dick) School of Veterinary Studies is a one-of-a-kind centre of excellence in clinical activity, teaching and research. Our purpose-built campus, set against the backdrop of the beautiful Pentland Hills Regional Park, is home to more than 800 staff and almost 1400 students, all of whom contribute to our exceptional community ethos.  

The School comprises:  

The Roslin Institute    

The Roslin Innovation Centre  

The Hospital for Small Animals  

Equine Veterinary Services  

Farm Animal Services  

Easter Bush Pathology  

The Animal Welfare Centre  

We represent the largest concentration of animal science-related expertise in Europe, impacting local, regional, national and international communities in terms of economic growth, the provision of clinical services and the advancement of scientific knowledge.